Kimberly E. Vanover, SVP, Early Stage Clinical Development at Intra-Cellular Therapies, Inc. (ITCI), sold 10,156 shares at $11.37 ($117K) on 2019-01-04, disclosed to the SEC on 2019-01-08.
Open-market sale of $117k ITCI by SVP, Early Stage Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.37 | 7,380 | $84K | 71.7% |
| 2 | $11.81 | 2,184 | $26K | 22.0% |
| 3 | $12.29 | 592 | $7K | 6.2% |
| Total | $11.52 avg | 10,156 | $117K | 100% |
| Filing → |
| ITCI | SELL | 2018-01-05 | $21K | — | Filing → |
| ITCI | SELL | 2017-01-09 | $13K | — | Filing → |
| ITCI | SELL | 2016-12-19 | $143K | — | Filing → |